FDA’s Top Vaccine Official Resigns, Citing Kennedy’s "Misinformation and Lies"
WASHINGTON – In a stunning development that has sent shockwaves through the public health community, Dr. Peter Marks, the director of the Food and Drug Administration’s Center for Biologics Evaluation and Research (CBER) and the agency’s top vaccine official, has announced his resignation, effective April 5th. His departure comes amidst a growing controversy surrounding Health Secretary Robert F. Kennedy Jr.’s public pronouncements on vaccine safety, which have been widely criticized by scientists and medical professionals as promoting misinformation. In a scathing resignation letter obtained by the Associated Press, Marks accused Kennedy of prioritizing "misinformation and lies" over scientific evidence and transparency, making his continued service untenable.
Marks’ letter, addressed to Acting FDA Commissioner Sara Brenner, paints a stark picture of the escalating tension between the agency’s scientific integrity and the Secretary’s personal beliefs. He states that while he was "willing to work" with Kennedy to address his concerns about vaccine safety, he found the Secretary unreceptive to factual evidence and reasoned discussion. "It has become clear that truth and transparency are not desired by the Secretary, but rather he wishes subservient confirmation of his misinformation and lies," Marks wrote, highlighting the irreconcilable differences that ultimately led to his decision. This resignation comes on the heels of reports, attributed to a former FDA official, that Kennedy offered Marks an ultimatum: resign or be fired.
The controversy surrounding Kennedy’s stance on vaccines has been brewing since his Senate confirmation hearings, during which he pledged not to interfere with established vaccine policy. However, his subsequent actions have directly contradicted this promise. Kennedy has publicly questioned the safety and efficacy of childhood vaccines, echoing debunked theories and conspiracy narratives that have been thoroughly refuted by decades of scientific research and consensus within the medical community. This stance has sparked widespread alarm among public health experts, who warn that such misinformation could erode public trust in vaccines and lead to a resurgence of preventable diseases.
Marks, a highly respected figure in the scientific community, played a pivotal role in the FDA’s rapid approval of COVID-19 vaccines, spearheading efforts to ensure their safety and efficacy. He was also instrumental in the launch of "Operation Warp Speed," the Trump administration’s initiative to accelerate vaccine development and distribution. Ironically, Marks faced criticism from then-President Trump, who blamed the timing of vaccine approvals for his 2020 election loss. Now, his departure comes under an administration ostensibly committed to scientific integrity, yet seemingly undermining it from within.
The reaction to Marks’ resignation has been swift and overwhelmingly negative. Leading vaccine expert Dr. Paul Offit described the situation as "a sad day for America’s children," emphasizing the potential consequences of undermining public confidence in vaccines. Former FDA Commissioner Dr. Robert Califf echoed these concerns, stating that the situation "should be frightening" for anyone who values science-based policymaking. Their statements underscore the widespread anxiety within the scientific and medical communities about the implications of Kennedy’s actions and the potential erosion of scientific integrity at the highest levels of government.
Marks’ departure is the latest development in a period of significant upheaval at the Department of Health and Human Services (HHS). The department recently announced plans to lay off 10,000 employees and close several agencies, a move that has been met with criticism from both inside and outside the government. Kennedy’s public comments, in which he referred to HHS as a "sprawling bureaucracy" and criticized its 82,000 employees, have further fueled concerns about the direction of the department under his leadership. The resignation of Dr. Marks, a respected scientist and public servant, adds another layer of complexity to this already tumultuous situation, raising serious questions about the future of science-based decision-making at HHS and the broader implications for public health in the United States. The loss of such a crucial figure during a time of ongoing public health challenges further underscores the potential consequences of prioritizing personal beliefs over scientific evidence in policy decisions.